High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin
The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Abstract
In thalassemia, deficient globin-chain production during erythropoiesis results in anemia. Thalassemia may be further complicated by iron overload (frequently exacerbated by blood transfusion), which induces numerous endocrine diseases, hepatic cirrhosis, cardiac failure and even death. Accumulation of iron in the absence of blood transfusions may result from inappropriate suppression of the iron-regulating peptide hepcidin by an erythropoietic mechanism. To test this hypothesis, we examined erythroblast transcriptome profiles from 15 healthy, nonthalassemic donors. Growth differentiation factor 15 (GDF15), a member of the transforming growth factor-beta superfamily, showed increased expression and secretion during erythroblast maturation. Healthy volunteers had mean GDF15 serum concentrations of 450 +/- 50 pg/ml. In comparison, individuals with beta-thalassemia syndromes had elevated GDF15 serum levels (mean 66,000 +/- 9,600 pg/ml; range 4,800-248,000 pg/ml; P < 0.05) that were positively correlated with the levels of soluble transferrin receptor, erythropoietin and ferritin. Serum from thalassemia patients suppressed hepcidin mRNA expression in primary human hepatocytes, and depletion of GDF15 reversed hepcidin suppression. These results suggest that GDF15 overexpression arising from an expanded erythroid compartment contributes to iron overload in thalassemia syndromes by inhibiting hepcidin expression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Growth-differentiation factor (GDF)-15, whose levels are increased in thalassemia and AI with or without ID, also inhibits HAMP expression [60, 64].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“However, in being the primary iron source for erythropoiesis, TF also indirectly regulates HAMP expression via erythroid progenitor-derived mediators, suggesting that the pathways of HAMP regulation are interconnected [59–61].”
From Iron deficiency or anemia of inflammation?: Differential diagnosis and mechanisms of anemia of inflammation (2016) · cites this paper as [60]
In the citing paper
“Growth differentiation factor 15 (GDF-15) and twisted gastrulation homolog 1 (TWSG1) have been identified as candidate erythrokines, although not erythroblast-specific, that have the potential to suppress hepcidin under conditions of increased erythropoietic activity.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“GDF15 is an iron- and O2-regulated (HIF-independent) member of the TGF-β superfamily, which is secreted from maturing erythroblasts and has been shown to suppress hepcidin transcription in primary human hepatocytes and hepatoma cells”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
In the citing paper
“This is in contrast to previous reports where higher doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.”
From Regulation of erythropoiesis by hypoxia-inducible factors (2013) · cites this paper as [214]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556
Weatherall, D. J., & Clegg, J. B. (2001) · Wiley eBooks · doi:10.1002/9780470696705 · Cited by 1,069
Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression
Babitt, J. L., Huang, F. W., Wrighting, D. M., Xia, Y., Sidis, Y., Samad, T. A., Campagna, J. A., Chung, R. T., Schneyer, A. L., Woolf, C. J., et al. (2006) · Nature Genetics · doi:10.1038/ng1777 · Cited by 1,026 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundRund, D., & Rachmilewitz, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050436 · Cited by 939
(1973) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1973.tb111034.x · Cited by 811
Regulation of Iron Metabolism by Hepcidin
Nemeth, E., & Ganz, T. (2006) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.26.061505.111303 · Cited by 756
Self-citationA role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression
Wang, R.-H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L., et al. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.10.010 · Cited by 614 · cited 1×
“Recently, transforming growth factor-β (TGFB) superfamily members have been identified as regulators of hepcidin expressio”
BackgroundSelf-citationXu, J., Kimball, T. R., Lorenz, J. N., Brown, D. A., Bauskin, A. R., Klevitsky, R., Hewett, T. E., Breit, S. N., & Molkentin, J. D. (2006) · Circulation Research · doi:10.1161/01.res.0000202804.84885.d0 · Cited by 506 · cited 1×
“Studies in cardiomyocytes suggest that GDF15 activates Smad2/3 signalin”
BackgroundLarge-Scale Delineation of Secreted Protein Biomarkers Overexpressed in Cancer Tissue and Serum
Welsh, J. B., Sapinoso, L. M., Kern, S. G., Brown, D. A., Liu, T., Bauskin, A. R., Ward, R. L., Hawkins, N. J., Quinn, D. I., Russell, P. J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530278100 · Cited by 503 · cited 1×
“Elevated serum GDF15 concentrations have been reported in a variety of cancer”
BackgroundThe transforming growth factor-β superfamily of receptors
de Caestecker, M. (2004) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2003.10.004 · Cited by 464
Cited by
Weiss, G., & Goodnough, L. T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041809 · Cited by 3,800
Two to tango: Regulation of Mammalian iron metabolism
Hentze, M. W., Muckenthaler, M. U., Galy, B., & Camaschella, C. (2010) · Cell · doi:10.1016/j.cell.2010.06.028 · Cited by 2,120
A Red carpet for iron metabolism
Muckenthaler, M. U., Rivella, S., Hentze, M. W., & Galy, B. (2017) · Cell · doi:10.1016/j.cell.2016.12.034 · Cited by 1,319
Ganz, T., & Nemeth, E. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2012.01.014 · Cited by 1,282
Self-citationWeiss, G., Ganz, T., & Goodnough, L. T. (2019) · Blood · doi:10.1182/blood-2018-06-856500 · Cited by 1,219
Self-citationIdentification of erythroferrone as an erythroid regulator of iron metabolism
Kautz, L., Jung, G., Valore, E. V., Rivella, S., Nemeth, E., & Ganz, T. (2014) · Nature Genetics · doi:10.1038/ng.2996 · Cited by 1,127
Self-citationGanz, T. (2013) · Physiological Reviews · doi:10.1152/physrev.00008.2013 · Cited by 1,122
“GDF-15, a BMP family member whose serum concentrations are greatly increased in iron-loading anemias (32, 125, 236, 237), has been proposed as a hepcidin suppressor in -thalassemia and in congenital dyserythropoietic anemias, but its contribution to hepcidin suppression and iron overload in these conditions remains un…”
BackgroundSelf-citationRegulation of cellular iron metabolism
Wang, J., & Pantopoulos, K. (2011) · Biochemical Journal · doi:10.1042/bj20101825 · Cited by 986
Hepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962
Self-citationRegulation of erythropoiesis by hypoxia-inducible factors
Haase, V. H. (2013) · Blood Reviews · doi:10.1016/j.blre.2012.12.003 · Cited by 787
“doses of GDF15 were needed to achieve hepcidin suppression in human HuH-7 hepatoma cells and in primary hepatocytes, while low dose GDF15 treatment increased hepcidin.(213) While demonstrated in mice, studies in humans receiving recombinant EPO have not yet shown a sig-”
BackgroundCao, A., & Galanello, R. (2010) · Genetics in Medicine · doi:10.1097/gim.0b013e3181cd68ed · Cited by 722
Camaschella, C. (2019) · Blood · doi:10.1182/blood-2018-05-815944 · Cited by 702
Hepcidin and the iron-infection axis
Drakesmith, H., & Prentice, A. M. (2012) · Science · doi:10.1126/science.1224577 · Cited by 686
Hereditary Hemochromatosis: Pathogenesis, Diagnosis, and Treatment
Pietrangelo, A. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.013 · Cited by 615
The Role of Hepcidin in Iron Metabolism
Nemeth, E., & Ganz, T. (2009) · Acta Haematologica · doi:10.1159/000243791 · Cited by 607
“Two proteins produced by erythroid precursors, growth differentiation factor 15 (GDF15) and twisted gastrulation protein (TWSG1), have been proposed to mediate hepcidin suppression in anemias with ineffective erythropoiesis [”
BackgroundSelf-citationMechanisms of mammalian iron homeostasis
Pantopoulos, K., Porwal, S. K., Tartakoff, A., & Devireddy, L. (2012) · Biochemistry · doi:10.1021/bi300752r · Cited by 598
Iron Overload in Human Disease
Fleming, R. E., & Ponka, P. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1004967 · Cited by 587
The serine protease TMPRSS6 is required to sense iron deficiency
Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E. M. Y., et al. (2008) · Science · doi:10.1126/science.1157121 · Cited by 578
GDF15 Is an Inflammation-Induced Central Mediator of Tissue Tolerance
Luan, H. H., Wang, A., Hilliard, B. K., Carvalho, F., Rosen, C. E., Ahasic, A. M., Herzog, E. L., Kang, I., Pisani, M. A., Yu, S., et al. (2019) · Cell · doi:10.1016/j.cell.2019.07.033 · Cited by 527
“Very few exceptions exist to this general rule—perhaps the best described of which is the extremely high levels of GDF15 reported in patients with thalassemia, a disease that is not generally associated with elevated inflammatory biomarkers (Tanno et al., 2007).”
Regulation of iron transport and the role of transferrin
Gkouvatsos, K., Papanikolaou, G., & Pantopoulos, K. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.10.013 · Cited by 518
“Serum from thalassemic patients or recombinant GDF15 incompletely suppressed hepcidin in human hepatocyte cultures [232].”
BackgroundIron Homeostasis and the Inflammatory Response
Wessling-Resnick, M. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.012809.104804 · Cited by 480
Advances in pathogenesis and therapeutic strategies for osteoporosis
Song, S., Guo, Y., Yang, Y., & Fu, D. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108168 · Cited by 476
Hepcidin and disorders of iron metabolism
Ganz, T., & Nemeth, E. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-050109-142444 · Cited by 466
Self-citationRegulation of iron acquisition and storage: consequences for iron-linked disorders
De Domenico, I., McVey Ward, D., & Kaplan, J. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2295 · Cited by 464
Regulation of the Iron Homeostatic Hormone Hepcidin
Sangkhae, V., & Nemeth, E. (2017) · Advances in Nutrition · doi:10.3945/an.116.013961 · Cited by 443
Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.16 · Cited by 430
Theurl, I., Aigner, E., Theurl, M., Nairz, M., Seifert, M., Schroll, A., Sonnweber, T., Eberwein, L., Witcher, D. R., Murphy, A. T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195651 · Cited by 421
Rachmilewitz, E. A., & Giardina, P. J. (2011) · Blood · doi:10.1182/blood-2010-08-300335 · Cited by 417
A Heme Export Protein Is Required for Red Blood Cell Differentiation and Iron Homeostasis
Keel, S. B., Doty, R. T., Yang, Z., Quigley, J. G., Chen, J., Knoblaugh, S., Kingsley, P. D., De Domenico, I., Vaughn, M. B., Kaplan, J., et al. (2008) · Science · doi:10.1126/science.1151133 · Cited by 404
Liver iron sensing and body iron homeostasis
Wang, C.-Y., & Babitt, J. L. (2019) · Blood · doi:10.1182/blood-2018-06-815894 · Cited by 360
Tanno, T., Porayette, P., Sripichai, O., Noh, S.-J., Byrnes, C., Bhupatiraju, A., Lee, Y. T., Goodnough, J. B., Harandi, O., Ganz, T., et al. (2009) · Blood · doi:10.1182/blood-2008-12-195503 · Cited by 352
Self-citationHypoxic regulation of erythropoiesis and iron metabolism
Haase, V. H. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00174.2010 · Cited by 347
Krieg, A. J., Rankin, E. B., Chan, D., Razorenova, O., Fernandez, S., & Giaccia, A. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00444-09 · Cited by 334
“Many of the genes that we identified as JMJD1A targets were factors involved in vascular dilation (ADM) (23), iron metabolism (GDF15) (47), and angiogenesis (ADM, EDN1, SERPINE1, and HMOX1) (27).”
BackgroundHypoxia-inducible factor regulates hepcidin via erythropoietin-induced erythropoiesis
Liu, Q., Davidoff, O., Niss, K., & Haase, V. H. (2012) · Journal of Clinical Investigation · doi:10.1172/jci63924 · Cited by 328
“Since very high levels of serum GDF15 were found in patients with α - and β -thalassemia, it was proposed that GDF15 is the BM-derived factor that suppresses hepcidin under conditions of stimulated erythropoiesis (24).”
InfluentialIron metabolism in the anemia of chronic disease
Weiss, G. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2008.08.006 · Cited by 322
“to iron overload in patients with thalassemia [229].”
BackgroundPlasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
Ashby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R. S., et al. (2009) · Kidney International · doi:10.1038/ki.2009.21 · Cited by 311
Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E., & Ganz, T. (2015) · Blood · doi:10.1182/blood-2015-07-658419 · Cited by 306
“We also examined the expression of growth differentiation factor 15 (GDF15) and twisted-gastrulation 1 (TWSG1), bonemorphogenetic protein family members that have been proposed as pathological suppressors of hepcidin in thalassemia.(24,25) Gdf15 expression was not increased in the marrow and was only mildly increased…”
BackgroundSelf-citationMembrane-bound serine protease matriptase-2 (Tmprss6) is an essential regulator of iron homeostasis
Folgueras, A. R., de Lara, F. M., Pendás, A. M., Garabaya, C., Rodríguez, F., Astudillo, A., Bernal, T., Cabanillas, R., López-Otín, C., & Velasco, G. (2008) · Blood · doi:10.1182/blood-2008-04-149773 · Cited by 305
An overview of molecular basis of iron metabolism regulation and the associated pathologies
Silva, B., & Faustino, P. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.03.011 · Cited by 300
“Two BMP familymembers,thegrowthdif-ferentiation factor 15 (GDF-15) and the twisted gastrulation 1 (TWSG-1) are up-regulated in pathologies that present an expanded but ineffective erythropoiesis, as β -thalassemia and congenital dyserythropoietic anemias [115 – 117] (Fig.”
BackgroundAtlas of the plasma proteome in health and disease in 53,026 adults
Deng, Y.-T., You, J., He, Y., Zhang, Y., Li, H.-Y., Wu, X.-R., Cheng, J.-Y., Guo, Y., Long, Z.-W., Chen, Y.-L., et al. (2025) · Cell · doi:10.1016/j.cell.2024.10.045 · Cited by 294
Evstatiev, R., & Gasche, C. (2012) · Gut · doi:10.1136/gut.2010.214312 · Cited by 293
“GDF-15 exerts a suppressive effect on hepcidin expression, contributing to iron overload in thalassaemia and similar disorders of erythropoiesis.(116) TWSG1 is another highly expressed serum protein in thalassaemia.”
BackgroundAnemia: progress in molecular mechanisms and therapies
Sankaran, V. G., & Weiss, M. J. (2015) · Nature Medicine · doi:10.1038/nm.3814 · Cited by 281
An activin receptor IIA ligand trap corrects ineffective erythropoiesis in β-thalassemia
Dussiot, M., Maciel, T. T., Fricot, A., Chartier, C., Negre, O., Veiga, J., Grapton, D., Paubelle, E., Payen, E., Beuzard, Y., et al. (2014) · Nature Medicine · doi:10.1038/nm.3468 · Cited by 279
The Regulation of Iron Absorption and Homeostasis.
Wallace, D. F. (2016) · PubMed Central · Cited by 365
Iron Deficiency and Raised Hepcidin in Idiopathic Pulmonary Arterial Hypertension
Rhodes, C. J., Howard, L. S., Busbridge, M., Ashby, D., Kondili, E., Gibbs, J. S. R., Wharton, J., & Wilkins, M. R. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.02.057 · Cited by 266
“Serum from patients with overactive erythropoiesis inhibits hepcidin expression in vitro (27) and recombinant human EPO administration lowers hepcidin levels in healthy volunteers (28).”
BackgroundInfluentialAnderson, E. R., & Shah, Y. M. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c120016 · Cited by 219
GDF15: a hormone conveying somatic distress to the brain
Lockhart, S. M., Saudek, V., & O’Rahilly, S. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa007 · Cited by 256
GDF15 linked to maternal risk of nausea and vomiting during pregnancy
Fejzo, M., Rocha, N., Cimino, I., Lockhart, S. M., Petry, C. J., Kay, R. G., Burling, K., Barker, P., George, A. L., Yasara, N., et al. (2024) · Nature · doi:10.1038/s41586-023-06921-9 · Cited by 204
“Beta-thalassaemia is a genetic disorder affecting red blood cells where extremely high levels of GDF15, found throughout life 4,5 , are thought to come from the expanded mass of stressed erythroblasts.”
Breit, S. N., Johnen, H., Cook, A. D., Tsai, V. W. W., Mohammad, M. G., Kuffner, T., Zhang, H. P., Marquis, C. P., Jiang, L., Lockwood, G., et al. (2011) · Growth Factors · doi:10.3109/08977194.2011.607137 · Cited by 247
“Although the production of MIC-1/GDF15 by the erythroid leukaemic cell line K562 has been known for some time, Tanno et al. (2007) found that it down-regulated hepcidin result- ing in increasing absorption and iron overload in thalassaemia.”
Hepcidin in Human Iron Disorders: Diagnostic Implications
Kroot, J. J., Tjalsma, H., Fleming, R. E., & Swinkels, D. W. (2011) · Clinical Chemistry · doi:10.1373/clinchem.2009.140053 · Cited by 246
Molecular Mechanisms of Hepcidin Regulation: Implications for the Anemia of CKD
Babitt, J. L., & Lin, H. Y. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.12.030 · Cited by 235
The long history of iron in the Universe and in health and disease
Sheftel, A. D., Mason, A. B., & Ponka, P. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.08.002 · Cited by 234
Pinto, J. P., Ribeiro, S., Pontes, H., Thowfeequ, S., Tosh, D., Carvalho, F., & Porto, G. (2008) · Blood · doi:10.1182/blood-2007-08-106195 · Cited by 239
The Spectrum of Achalasia: Lessons From Studies of Pathophysiology and High-Resolution Manometry
Kahrilas, P. J., & Boeckxstaens, G. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.08.038 · Cited by 235
Reducing TMPRSS6 ameliorates hemochromatosis and β-thalassemia in mice
Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., Watt, A., Freier, S., Monia, B. P., & Rivella, S. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66969 · Cited by 222
“Increased expression levels of Id1 and Gdf15 in erythroid cells have been associated, respectively, with increased survival of erythroid cells and IE (38, 39).”
Song, S.-N. J., Tomosugi, N., Kawabata, H., Ishikawa, T., Nishikawa, T., & Yoshizaki, K. (2010) · Blood · doi:10.1182/blood-2010-03-271791 · Cited by 228
The Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
“Other hematopoiesis-derived factors, such as the growth differentiation factor 15 (GDF15), can also reduce hepcidin expression, but their relative importance in the setting of anemia of inflammation appears to be limited [65,187].”
Hepcidin: regulation of the master iron regulator
Rishi, G., Wallace, D. F., & Subramaniam, V. N. (2015) · Bioscience Reports · doi:10.1042/bsr20150014 · Cited by 223
Zhao, N., Zhang, A.-S., & Enns, C. A. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67225 · Cited by 209
“GDF15 concentrations in the blood from thalassemia patients were also increased compared with those of healthy individuals (83).”
The regulation of iron transport
Frazer, D. M., & Anderson, G. J. (2014) · BioFactors · doi:10.1002/biof.1148 · Cited by 216
“Two proteins, growth differentiation factor 15 (GDF15) [52] and twisted gastrulation homolog 1 (TWGS1) [53] have been proposed to perform this task.”
BackgroundMimeault, M., & Batra, S. K. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22196 · Cited by 208
“…risk of developing diverse diseases such as thalassemia, and congenital dyserythropoietic anemia (CDA), characterized by ineffective P L E I O T R O P I C F U N C T I O N S O F M I C - 1 I N C A N C E R 627 erythropoiesis and increased iron absorption (Tanno et al., 2007; Tamary et al., 2008).”
BackgroundIron Regulation: Macrophages in Control
Sukhbaatar, N., & Weichhart, T. (2018) · Pharmaceuticals · doi:10.3390/ph11040137 · Cited by 200
“Other hepcidin inhibitory factors were identified, including members of the growth factor beta (TGF-β) superfamily comprising growth differentiation factor 15 (GDF15), transforming growth factor beta (TGF-β), twisted gastrulation BMP signaling modulator 1 (TWSG1) and erythroid factor erythropoietin (Epo) [83,84].”
BackgroundHow I treat transfusional iron overload
Hoffbrand, A. V., Taher, A., & Cappellini, M. D. (2012) · Blood · doi:10.1182/blood-2012-05-370098 · Cited by 207
Concise Review: Growth Differentiation Factor 15 in Pathology: A Clinical Role?
Corre, J., Hébraud, B., & Bourin, P. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0055 · Cited by 208
Iron absorption and metabolism
Anderson, G. J., Frazer, D. M., & McLaren, G. D. (2009) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32831ef1f7 · Cited by 204
Schwartz, A. J., Das, N. K., Ramakrishnan, S. K., Jain, C., Jurkovic, M. T., Wu, J., Nemeth, E., Lakhal-Littleton, S., Colacino, J. A., & Shah, Y. M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci122359 · Cited by 203
Out of Balance—Systemic Iron Homeostasis in Iron-Related Disorders
Steinbicker, A., & Muckenthaler, M. (2013) · Nutrients · doi:10.3390/nu5083034 · Cited by 195
“15 GDF15 Possible erythropoietic-derived suppressor of hepcidin levels [44–46].”
BackgroundGinzburg, Y., & Rivella, S. (2011) · Blood · doi:10.1182/blood-2011-03-283614 · Cited by 201
Disorders of iron metabolism. Part 1: molecular basis of iron homoeostasis
Muñoz, M., García-Erce, J. A., & Remacha, Á. F. (2011) · Journal of Clinical Pathology · doi:10.1136/jcp.2010.079046 · Cited by 200
“GDF15 and TWSTG1 are members of the TGF-β superfamily and are released under conditions of iron-restricted erythropoiesis. GDF15 is secreted by haemoglobinised erythroblasts during the final stages of erythropoiesis, which has been demonstrated to suppress hepcidin expression in vitro,”
BackgroundDing, Q., Mracek, T., Gonzalez-Muniesa, P., Kos, K., Wilding, J., Trayhurn, P., & Bing, C. (2009) · Endocrinology · doi:10.1210/en.2008-0952 · Cited by 193
Pathophysiology and Clinical Manifestations of the -Thalassemias
Nienhuis, A. W., & Nathan, D. G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011726 · Cited by 180
“Factors released from apoptotic erythroblasts include growth differentiation factor 15 (GDF15), a member of the transforming growth factor-b superfamily (Tanno et al. 2007).”
BackgroundIneffective erythropoiesis and thalassemias
Rivella, S. (2009) · Current Opinion in Hematology · doi:10.1097/moh.0b013e32832990a4 · Cited by 185
Role of hepcidin in the pathophysiology and diagnosis of anemia
D'Angelo, G. (2013) · Blood Research · doi:10.5045/br.2013.48.1.10 · Cited by 185
“In ineffective erythropoiesis syndromes, the suppression of hepcidin production is regulated by GDF15 and TWSG I [1, 14, 15].”
BackgroundTransferrin therapy ameliorates disease in β-thalassemic mice
Li, H., Rybicki, A. C., Suzuka, S. M., von Bonsdorff, L., Breuer, W., Hall, C. B., Cabantchik, Z. I., Bouhassira, E. E., Fabry, M. E., & Ginzburg, Y. Z. (2010) · Nature Medicine · doi:10.1038/nm.2073 · Cited by 192
“This increase in hepcidin is probably due to diminished release from erythroid precursors of an as yet incompletely characterized suppressor of hepcidin functio”
BackgroundAshby, D. R., Gale, D. P., Busbridge, M., Murphy, K. G., Duncan, N. D., Cairns, T. D., Taube, D. H., Bloom, S. R., Tam, F. W. K., Chapman, R., et al. (2010) · Haematologica · doi:10.3324/haematol.2009.013136 · Cited by 191
“Firstly, GDF15 has been shown to suppress hepcidin expression in cultured hepatocytes, and secondly, it circulates at extremely high levels in patients with beta thalassemia, potentially explaining their inappropriate hepcidin suppression in spite of iron overload.(25,26) This hypothesis was strengthened by the recent…”
BackgroundHypoxia-inducible factors link iron homeostasis and erythropoiesis
Shah, Y. M., & Xie, L. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.12.031 · Cited by 187
Physiology and pathophysiology of iron in hemoglobin-associated diseases
Coates, T. D. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.03.039 · Cited by 181
“The increase in hepcidin would be consistent with a decrease in putative erythroid-derived suppressors of hepcidin [56, 61, 97] because of reduced ineffective erythropoiesis.”
BackgroundSun, C. C., Vaja, V., Babitt, J. L., & Lin, H. Y. (2012) · American Journal of Hematology · doi:10.1002/ajh.23110 · Cited by 185
“Erythropoietic stimulators [17,18] and hypoxia [19,20] also negatively regulate hepcidin to increase iron availability for erythropoiesis.”
BackgroundLanser, L., Fuchs, D., Kurz, K., & Weiß, G. (2021) · Nutrients · doi:10.3390/nu13113732 · Cited by 209
The liver: conductor of systemic iron balance
Meynard, D., Babitt, J. L., & Lin, H. Y. (2014) · Blood · doi:10.1182/blood-2013-06-427757 · Cited by 177
“Growth differentiation factor 15 (GDF15) and twisted gastrulation-1 (TWSG1) are potentials mediators of bone marrow signaling because their expression is stimulated under ineffective erythropoiesis conditions.(100,101) However, a nonredundant role for these proteins as erythroid regulators is excluded.”
BackgroundNew insights into iron regulation and erythropoiesis
Kim, A., & Nemeth, E. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000132 · Cited by 171
Iron regulation and erythropoiesis
Nemeth, E. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3282f73335 · Cited by 181
Pathogenesis and management of iron toxicity in thalassemia
Hershko, C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05544.x · Cited by 176
Hsu, C. C.-S., Senussi, N. H., Fertrin, K. Y., & Kowdley, K. V. (2022) · Hepatology Communications · doi:10.1002/hep4.2012 · Cited by 191
“[104,106] ICT with DFO or DFX has been shown to also reverse hepatic fibrosis (by two stages) or maintains stability of fibrosis (−1, 0, +1) in 82.6% of patients with TDT, independent of LIC or HCV positivity.”
BackgroundInfluentialMastrogiannaki, M., Matak, P., Mathieu, J. R. R., Delga, S., Mayeux, P., Vaulont, S., & Peyssonnaux, C. (2012) · Haematologica · doi:10.3324/haematol.2011.056119 · Cited by 161
“GDF15 and TWSG1 have been proposed as potential candidates.(34,35) However, administration of erythropoietin to healthy volunteers has been shown to suppress circulating hepcidin, independently of GDF15.”
BackgroundHepcidin-ferroportin axis in health and disease
Ginzburg, Y. Z. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.01.002 · Cited by 186
“Circulating growth differentiation factor 15 (GDF15) is increased in patients with several congenital and acquired anemias and correlates with concurrent low hepcidin (Tanno et al., 2007).”
BackgroundRegulation of Hepcidin and Iron-Overload Disease
Lee, P. L., & Beutler, E. (2009) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092205 · Cited by 174
“The molecule responsible for this activity was identified as GDF15, a member of the transforming growth factor β superfamily (103).”
BackgroundThe Hepcidin-Ferroportin System as a Therapeutic Target in Anemias and Iron Overload Disorders
Ganz, T., & Nemeth, E. (2011) · Hematology · doi:10.1182/asheducation-2011.1.538 · Cited by 172
Self-citationIron and Immunity: Immunological Consequences of Iron Deficiency and Overload
Cherayil, B. J. (2010) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-010-0095-9 · Cited by 170
“2007), increased levels of growth differentiation factor 15 in certain hemolytic anemias (Tanno et al. 2007), and cleavage of membrane HJV by the serine protease matriptase 2 in response to iron deficiency (Silvestri et al.”
Flamme, I., Oehme, F., Ellinghaus, P., Jeske, M., Keldenich, J., & Thuss, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111838 · Cited by 170
“Hepatic expression of hepcidin, which is an important pathogenic factor responsible for disturbed iron utilization in inflammatory anemia, is known to be reduced after stimulation of the bone marrow with EPO [56,57].”
BackgroundNramp1 promotes efficient macrophage recycling of iron following erythrophagocytosis in vivo
Soe-Lin, S., Apte, S. S., Andriopoulos, B., Andrews, M. C., Schranzhofer, M., Kahawita, T., Garcia-Santos, D., & Ponka, P. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900808106 · Cited by 167
“Lastly, GDF15, a humoral factor produced by red-bloodcell precursors, has been shown to decrease the production of hepcidin, but only under the pathological setting of -thalassemia (29).”
BackgroundErythropoietic regulators of iron metabolism
Ganz, T. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.07.003 · Cited by 153
Self-citationIron Metabolism: Interactions with Normal and Disordered Erythropoiesis
Ganz, T., & Nemeth, E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011668 · Cited by 152
“…factor (GDF) 15 and twisted gastrulation (TWSG) 1, have been proposed to play a role in pathological hepcidin suppression during ineffective erythropoiesis (Tanno et al. 2007, 2009; Casanovas et al. 2011) but their specific regulatory role in iron homeostasis or pathology remains to be established.”
BackgroundSelf-citationReview article: the iron overload syndromes
Siddique, A., & Kowdley, K. V. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05051.x · Cited by 162
Deletion of TMPRSS6 attenuates the phenotype in a mouse model of β-thalassemia
Nai, A., Pagani, A., Mandelli, G., Lidonnici, M. R., Silvestri, L., Ferrari, G., & Camaschella, C. (2012) · Blood · doi:10.1182/blood-2012-01-401885 · Cited by 161
Wang, L., Johnson, E. E., Shi, H. N., Walker, W. A., Wessling-Resnick, M., & Cherayil, B. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.4.2723 · Cited by 159
“A similar situation may prevail in thalassemia, where it has been shown recently that hepcidin expression is suppressed by high levels of growth differentiation factor 15 (56).”
BackgroundPasricha, S.-R., Frazer, D. M., Bowden, D. K., & Anderson, G. J. (2013) · Blood · doi:10.1182/blood-2012-12-471441 · Cited by 152
Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis
Iolascon, A., De Falco, L., & Beaumont, C. (2009) · Haematologica · doi:10.3324/haematol.13619 · Cited by 155
“patients with thalassemia, were responsible for the inhibition of hepcidin expression.(75) However in thalassemia major, transfusions suppress endogenous erythropoiesis and hepcidin levels tend to be high.”
BackgroundSchledzewski, K., Géraud, C., Arnold, B., Wang, S., Gröne, H.-J., Kempf, T., Wollert, K. C., Straub, B. K., Schirmacher, P., Demory, A., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44740 · Cited by 154
Iron Homeostasis: Recently Identified Proteins Provide Insight into Novel Control Mechanisms
Zhang, A.-S., & Enns, C. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.r800017200 · Cited by 153
Metadata
- Authors
- Tanno, T., Bhanu, N. V., Oneal, P. A., Goh, S.-H., Staker, P., Lee, Y. T., Moroney, J. W., Reed, C. H., Luban, N. L., Wang, R.-H., Eling, T. E., Childs, R., Ganz, T., Leitman, S. F., Fucharoen, S., & Miller, J. L.
- Affiliations
- National Institutes of Health (US)
- Walter Reed National Military Medical Center (US)
- Children's National (US)
- University of California, Los Angeles (US)
- Mahidol University (TH)
- Corresponding author
- Miller, Jeffery L
- Venue
- Nature Medicine
- Published
- 2007-08-26
- Volume
- 13
- Issue
- 9
- Pages
- 1096-1101
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2107423980
- Cited by
- 854
- References
- 32
- Citations by year
- 2026: 15 · 2025: 19 · 2024: 15 · 2023: 26 · 2022: 27 · 2021: 52 · 2020: 40 · 2019: 37 · 2018: 44 · 2017: 45 · 2016: 47 · 2015: 55 · 2014: 55 · 2013: 54 · 2012: 53
- FWCI
- 40.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › GDF15 and Related Biomarkers
- Keywords
- GDF15, growth differentiation factor 15, beta-thalassemia, hepcidin, iron overload, erythropoiesis, erythroblasts, soluble transferrin receptor, ferritin, erythropoietin, hepatocytes, iron regulation
- MeSH terms
- Gene Expression Regulation, Humans, Reference Values, RNA, Messenger, Thalassemia, Transcription, Genetic, Polymerase Chain Reaction, Cytokines, Gene Expression Profiling, Antimicrobial Cationic Peptides, Growth Differentiation Factor 15, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.